817641-86-4 Usage
Description
1-Tert-Butyl-3-Cyclobutyl-1H-pyrazol-5-amine is a pyrazole derivative with a molecular formula of C11H19N3. It features a tert-butyl group and a cyclobutyl group attached to the nitrogen atom, giving it unique structural and biological properties. This chemical compound holds potential for applications in both pharmaceutical and agrochemical industries, serving as a building block for the synthesis of various organic compounds and possibly as a pharmacological or pesticide agent.
Uses
Used in Pharmaceutical Industry:
1-Tert-Butyl-3-Cyclobutyl-1H-pyrazol-5-amine is used as a building block for the synthesis of pharmaceutical compounds due to its unique structure and potential biological activities. Its presence in drug development may contribute to the creation of new medications with specific therapeutic effects.
Used in Agrochemical Industry:
In the agrochemical sector, 1-Tert-Butyl-3-Cyclobutyl-1H-pyrazol-5-amine is used as a building block for the synthesis of agrochemical compounds, potentially leading to the development of new pesticides with improved efficacy and selectivity.
Further research and testing are required to fully explore and harness the potential of 1-Tert-Butyl-3-Cyclobutyl-1H-pyrazol-5-amine in these industries.
Check Digit Verification of cas no
The CAS Registry Mumber 817641-86-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,1,7,6,4 and 1 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 817641-86:
(8*8)+(7*1)+(6*7)+(5*6)+(4*4)+(3*1)+(2*8)+(1*6)=184
184 % 10 = 4
So 817641-86-4 is a valid CAS Registry Number.
817641-86-4Relevant articles and documents
N-SULFONYLATED PYRAZOLO[3,4-B]PYRIDIN-6-CARBOXAMIDES AND METHOD OF USE
-
, (2017/04/23)
The present invention provides for compounds of formula (I) wherein R1, R2, R3, R4, R5, and R6 have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions mediated and modulated by CFTR, including cystic fibrosis, Sj?gren's syndrome, pancreatic insufficiency, chronic obstructive lung disease, and chronic obstructive airway disease. Also provided are pharmaceutical compositions comprised of one or more compounds of formula (I).
PYRAZOLO`3,4-B!PYRIDIN-6-ONES AS GSK-3 INHIBITORS
-
Page 20, (2010/02/10)
The invention provides compounds of formula (I), the stereoisomers and prodrugs thereof, and the pharmaceutically acceptable salts of the compounds, stereoisomers, and prodrugs, wherein R1, R2, and R3 are as defined herein; pharmaceutical compositions thereof; and use thereof in the treatment of, inter alia, conditions, diseases, and symptoms such as diabetes, dementia, Alzheimer's Disease, stroke, schizophrenia, depression, hair loss, and cancer.
